Literature DB >> 7358830

Age-related changes of calcitonin secretion in females.

I M Shamonki, A M Frumar, I V Tataryn, D R Meldrum, B H Davidson, J G Parthemore, H L Judd, L J Deftos.   

Abstract

Calcitonin secretion was studied in 50 normal females from 20--69 yr of age, with 10 subjects in each decade. Hormone measurements were made by RIA during response to a 10-min infusion of calcium (as the chloride salt) at 3 mg/kg BW. There was a progressive decrease of the calcium-stimulated plasma calcitonin with age. Linear regression analysis demonstrated a significant (P less than 0.05) negative correlation (r = 0.29) between calcitonin response and age. Postmenopausal females had a significantly (P less than 0.01) smaller calcitonin response than premenopausal females. The time of maximum calcitonin response progressively shifted from 10 min in the younger subjects to 20 min in the older subjects. These studies demonstrated that calcitonin secretion decreases with age in females. This decrease may play some role in the pathogenesis of the progressive loss of bone mass which occurs with aging in females.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7358830     DOI: 10.1210/jcem-50-3-437

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  7 in total

1.  Absence of evidence for a role of calcitonin in the etiology of femoral neck fracture.

Authors:  T R Beringer; J Ardill; H M Taggart
Journal:  Calcif Tissue Int       Date:  1986-11       Impact factor: 4.333

2.  Osteoporosis occurring in two patients receiving LHRH analogs for carcinoma of the prostate.

Authors:  M P Collinson; C J Tyrrel; C Hutton
Journal:  Calcif Tissue Int       Date:  1994-04       Impact factor: 4.333

3.  Age-associated C-cell hyperplasia in the human thyroid.

Authors:  W G Gibson; T C Peng; B P Croker
Journal:  Am J Pathol       Date:  1982-03       Impact factor: 4.307

4.  Suppressive effect of chronic glucocorticoid treatment on circulating calcitonin in man.

Authors:  V LoCascio; S Adami; L V Avioli; L Cominacini; G Galvanini; C Gennari; B Imbimbo; L A Scuro
Journal:  Calcif Tissue Int       Date:  1982-05       Impact factor: 4.333

5.  Calcitonin, estradiol, and hydroxyproline as parameters in the early diagnosis of involutional osteoporosis. The importance of the "second calcitonin phenomenon".

Authors:  L Ferrández; M Martín; M Fernández
Journal:  Arch Orthop Trauma Surg       Date:  1990       Impact factor: 3.067

6.  Procalcitonin's amino-terminal cleavage peptide is a bone-cell mitogen.

Authors:  D M Burns; J M Forstrom; K E Friday; G A Howard; B A Roos
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

7.  Evaluation of diffusely high uptake by the calvaria in bone scintigraphy.

Authors:  K Senda; S Itoh
Journal:  Ann Nucl Med       Date:  1987-09       Impact factor: 2.668

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.